Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Hal Cohen, D.O.
Internal Medicine · OLD ORCHARD BEACH, ME · NPI 1598728313
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 714 | 229 |
| Lisinopril | Lisinopril | 394 | 127 |
| Levothyroxine Sodium | Levothyroxine Sodium | 372 | 102 |
| Oxycodone Hcl | Oxycodone Hcl | 343 | 41 |
| Amlodipine Besylate | Amlodipine Besylate | 336 | 104 |
| Lorazepam | Lorazepam | 245 | 62 |
| Metformin Hcl | Metformin Hcl | 190 | 59 |
| Omeprazole | Omeprazole | 180 | 62 |
| Gabapentin | Gabapentin | 176 | 58 |
| Simvastatin | Simvastatin | 176 | 58 |
| Metoprolol Succinate | Metoprolol Succinate | 161 | 52 |
| Hydrochlorothiazide | Hydrochlorothiazide | 160 | 50 |
| Losartan Potassium | Losartan Potassium | 136 | 50 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 133 | 60 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 133 | 45 |
| Sertraline Hcl | Sertraline Hcl | 124 | 39 |
| Alendronate Sodium | Alendronate Sodium | 116 | 37 |
| Zolpidem Tartrate | Zolpidem Tartrate | 113 | 23 |
| Pravastatin Sodium | Pravastatin Sodium | 105 | 26 |
| Allopurinol | Allopurinol | 103 | 34 |
| Duloxetine Hcl | Duloxetine Hcl | 99 | 26 |
| Fluoxetine Hcl | Fluoxetine Hcl | 94 | 31 |
| Atenolol | Atenolol | 93 | 30 |
| Tramadol Hcl | Tramadol Hcl | 93 | 40 |
| Metformin Hcl Er | Metformin Hcl | 92 | 34 |
| Furosemide | Furosemide | 91 | 29 |
| Bupropion Xl | Bupropion Hcl | 89 | 27 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 86 | 26 |
| Pantoprazole Sodium | Pantoprazole Sodium | 84 | 27 |
| Clonazepam | Clonazepam | 82 | 23 |
| Carvedilol | Carvedilol | 78 | 24 |
| Trazodone Hcl | Trazodone Hcl | 78 | 31 |
| Eliquis | Apixaban | 77 | 23 |
| Alprazolam | Alprazolam | 76 | 25 |
| Metoprolol Tartrate | Metoprolol Tartrate | 70 | 19 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 67 | 16 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 66 | 23 |
| Ozempic | Semaglutide | 66 | 16 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 65 | 17 |
| Diazepam | Diazepam | 63 | 18 |
| Glipizide Er | Glipizide | 63 | 19 |
| Jardiance | Empagliflozin | 62 | 17 |
| Synthroid | Levothyroxine Sodium | 61 | 14 |
| Pregabalin | Pregabalin | 59 | 15 |
| Famotidine | Famotidine | 58 | 22 |
| Xarelto | Rivaroxaban | 55 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 53 | 18 |
| Prednisone | Prednisone | 50 | 31 |
| Warfarin Sodium | Warfarin Sodium | 50 | 11 |
| Ezetimibe | Ezetimibe | 49 | 11 |
| Glipizide | Glipizide | 49 | 18 |
| Montelukast Sodium | Montelukast Sodium | 47 | 15 |
| Tizanidine Hcl | Tizanidine Hcl | 47 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 47 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 45 | 16 |
| Potassium Chloride | Potassium Chloride | 45 | 16 |
| Tamsulosin Hcl | Tamsulosin Hcl | 45 | 16 |
| Valsartan | Valsartan | 41 | 13 |
| Escitalopram Oxalate | Escitalopram Oxalate | 34 | 18 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 34 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 33 | 12 |
| Chlorthalidone | Chlorthalidone | 31 | 12 |
| Januvia | Sitagliptin Phosphate | 31 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 31 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 30 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 30 | 12 |
| Aripiprazole | Aripiprazole | 29 | 13 |
| Azithromycin | Azithromycin | 29 | 24 |
| Paroxetine Hcl | Paroxetine Hcl | 28 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 27 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 26 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 25 | suppressed |
| Finasteride | Finasteride | 24 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 24 | suppressed |
| Lansoprazole | Lansoprazole | 23 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 23 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 22 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 21 | suppressed |
| Spironolactone | Spironolactone | 21 | suppressed |
| Nifedipine Er | Nifedipine | 20 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 19 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 19 | suppressed |
| Estradiol | Estradiol | 19 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 19 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 19 | 17 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 18 | 14 |
| Buspirone Hcl | Buspirone Hcl | 18 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 18 | suppressed |
| Methylphenidate Er | Methylphenidate Hcl | 18 | suppressed |
| Amoxicillin | Amoxicillin | 17 | 14 |
| Bupropion Hcl | Bupropion Hcl | 17 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 17 | suppressed |
| Lovastatin | Lovastatin | 17 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 16 | suppressed |
| Fluconazole | Fluconazole | 16 | 11 |
| Indomethacin | Indomethacin | 16 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 15 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 15 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 15 | 13 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Bumetanide | Bumetanide | 14 | suppressed |
| Fenofibrate | Fenofibrate | 14 | suppressed |
| Glyburide | Glyburide | 14 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 14 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 14 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 13 | 13 |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Mirtazapine | Mirtazapine | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 13 |
| Trulicity | Dulaglutide | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 12 | suppressed |
| Caplyta | Lumateperone Tosylate | 12 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Ibuprofen | Ibuprofen | 12 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 12 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Celecoxib | Celecoxib | 11 | suppressed |
| Fentanyl | Fentanyl | 11 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 11 | suppressed |
| Lamotrigine | Lamotrigine | 11 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Mupirocin | Mupirocin | 11 | suppressed |
| Novolin N Flexpen | Insulin Nph Human Isophane | 11 | suppressed |
| Olanzapine | Olanzapine | 11 | suppressed |
| Ondansetron Odt | Ondansetron | 11 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 11 | suppressed |
| Oxycontin | Oxycodone Hcl | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error